716 records found.
Jun 19, 2019
dMed Biopharmaceutical, a next generation CRO, announced the opening of its US Regulatory Affairs office in Washington DC to build a bridge for affordable innovative drugs for US patients
Jun 17, 2019
MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees
Jun 17, 2019
IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent's Paragon Gene Therapy for Orphan Inherited Retinal Diseases
Jun 11, 2019
Visiongain Report Claims There is Huge Potential Within the $57bn Biosimilar Drugs Market
Jun 10, 2019
Hoth Therapeutics to Begin Production of BioLexa Therapeutic for Upcoming Toxicology and Clinical Trials
Jun 05, 2019
Visiongain Publishes Global Wound Care Biologics Market 2019-2029 Report
Jun 04, 2019
Samsung BioLogics Enters New Era with "First-of-its-kind" Client-Centric CMO Deal
Jun 04, 2019
WuXi Biologics Hosts Successful Inaugural Investor Day
Jun 04, 2019
AGC Biologics Appoints New Chief Technical Officer
Jun 03, 2019
Intabio to Present Groundbreaking Innovation in Therapeutic Antibody Quality Characterization at ASMS Conference
Jun 03, 2019
Great Point Partners Makes $22 Million Equity Commitment to Bionova Scientific
Jun 03, 2019
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)
Jun 03, 2019
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma
Jun 03, 2019
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma
Jun 03, 2019
Tissue Engineering and Regeneration: Technologies and Global Markets
May 31, 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
May 30, 2019
Ampersand Capital Partners to Acquire Vibalogics GmbH
May 30, 2019
Milestone Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
May 30, 2019
Dr. Gustavo Mahler Joins Dynamk Capital as Venture Partner
May 29, 2019
ReForm Biologics Announces the Appointment of Alan Herman, Ph.D. and Fred Larimore, Ph.D. to Scientific Advisory Board

Pages